000739 普洛药业
2025/122024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)13.61915.90717.98718.71320.222
总资产报酬率 ROA (%)7.1128.0888.5159.39111.555
投入资产回报率 ROIC (%)8.92410.29410.81311.71714.865

边际利润分析
销售毛利率 (%)26.35723.84525.66423.90426.730
营业利润率 (%)10.94510.08210.6349.59312.517
息税前利润/营业总收入 (%)10.2979.0519.5898.59512.298
净利润/营业总收入 (%)9.1048.5759.1979.38110.685

收益指标分析
经营活动净收益/利润总额(%)93.27996.641103.197106.35891.460
价值变动净收益/利润总额(%)1.855-0.842-1.802-8.1625.990
营业外收支净额/利润总额(%)-0.438-0.730-1.2870.044-0.474

偿债能力分析
流动比率 (X)1.4691.4261.3271.2911.530
速动比率 (X)1.1701.1020.9960.9921.199
资产负债率 (%)48.48046.97251.20254.08844.055
带息债务/全部投入资本 (%)33.90432.02234.81740.54328.673
股东权益/带息债务 (%)190.779207.175181.084140.879243.917
股东权益/负债合计 (%)106.137112.75895.18984.771126.987
利息保障倍数 (X)-17.146-9.448-10.542-8.570-76.929

营运能力分析
应收账款周转天数 (天)63.98551.79452.77153.18050.936
存货周转天数 (天)86.49077.53181.98868.45564.175